ANTGX | VIHAX | ANTGX / VIHAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 6 years | 9 years | - |
Gain YTD | 0.755 | 5.984 | 13% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 560M | 8.38B | 7% |
Annual Yield % from dividends | 3.81 | 4.87 | 78% |
Returns for 1 year | -0.15 | 11.28 | -1% |
Returns for 3 years | 1.98 | 9.00 | 22% |
Returns for 5 years | 4.35 | 19.44 | 22% |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LSSIX | 31.73 | 0.54 | +1.73% |
Loomis Sayles Small Cap Growth Instl | |||
NARCX | 53.99 | 0.21 | +0.39% |
Voya Multi-Manager International Sm Cp C | |||
LSGRX | 30.81 | 0.05 | +0.16% |
Loomis Sayles Growth Y | |||
SIICX | 16.70 | 0.02 | +0.12% |
AlphaCentric Real Income C | |||
FBTDX | 124.82 | 0.08 | +0.06% |
Franklin Biotechnology Discovery C |